NCT06613022: (IASTM)

Effects of Instrument Assisted Soft Tissue Mobilization on Healthy Tissue Regarding Range of Motion and Grip Strength

Completed NA Last updated 25 September 2024

What this trial tests

NA trial testing Instrument Assisted Soft Tissue Mobilization first Control second in Healthy in 72 participants. Completed in 29 February 2024.

Timeline

8 January 2024

Primary endpoint
29 February 2024

29 February 2024

Quick facts

Lead sponsor	Beth Marschner
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	72
Start date	8 January 2024
Primary completion	29 February 2024
Estimated completion	29 February 2024
Sites	1 location across United States

Drugs / interventions tested

• Instrument Assisted Soft Tissue Mobilization first Control second
• Control first Instrument Assisted Soft Tissue Mobilization second

Conditions studied

• Healthy — all drugs for Healthy →

Sponsor

Beth Marschner

Who can join

18 and older, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to study the effects of instrument assisted soft tissue mobilization (IASTM) in healthy adult volunteers. The main questions it aims to answer are:

* Does IASTM treatment have an effect on range of motion (ROM) as measured in the elbow, wrist and thumb?
* Does IASTM treatment have an effect on grip strength? Researchers will compare pre-test and post-test IASTM treatment intervention data to the pre-test and post-test data of the no treatment control intervention to see if IASTM works to change ROM and/or grip strength.

Participants will:

* Complete a questionnaire on medical history and injury background
* Have elbow, wrist, and thumb range of motion (ROM) measurements taken on both upper extremities using a goniometer
* Undergo grip strength testing using a JAMAR hand dynamometer in three positions on both upper extremities
* Be randomly assigned to either IASTM first treatment group or the wait/control first group
* Receive IASTM treatment techniques including application of emollient to the skin to reduce friction on the surface followed by scanning the forearm wrist flexors and wrist extensors and the biceps and triceps using the HG8-Scanner tool and then the concave tool corresponding to the size of the structure being treated will be used (HG6-Large Multi-Curve, HG5-Medium Multi-Curve, HG4-Small Multi-Curve) in each direction for a total treatment time of 20 minutes for both upper extremities in all listed areas.
* Simply wait for 20 minutes (the duration of time treatment with IASTM would require) when assigned to the control group.
* Complete elbow, wrist and thumb range of motion and grip strength measurement testing at the end of the first session.
* Return within fourteen days after the first session in order to undergo the opposite experience (IASTM first means wait/control second and vice versa).
* Undergo the same baseline pre-test measurements for range of motion and grip strength as the first session.
* Experience the opposite treatment group for the same time period as the first session.
* Undergo the post-test range of motion and grip strength testing at the end of the second session for data comparison.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.